Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
Mallinckrodt
AstraZeneca
Express Scripts
McKesson
McKinsey

Last Updated: November 21, 2019

DrugPatentWatch Database Preview

SOLAGE Drug Profile

See Plans and Pricing

« Back to Dashboard

When do Solage patents expire, and what generic alternatives are available?

Solage is a drug marketed by Almirall and is included in one NDA. There is one patent protecting this drug.

This drug has thirteen patent family members in twelve countries.

The generic ingredient in SOLAGE is mequinol; tretinoin. Additional details are available on the mequinol; tretinoin profile page.

Summary for SOLAGE
International Patents:13
US Patents:1
Applicants:1
NDAs:1
Bulk Api Vendors: 48
Patent Applications: 2
Formulation / Manufacturing:see details
DailyMed Link:SOLAGE at DailyMed
Drug patent expirations by year for SOLAGE
Generic Entry Opportunity Date for SOLAGE
Generic Entry Date for SOLAGE*:
Constraining patent/regulatory exclusivity:
NDA:
Dosage:
SOLUTION;TOPICAL

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Synonyms for SOLAGE
11-cis Retinoic Acid
2999-EP0930075A1
2999-EP2270008A1
2999-EP2272510A1
2999-EP2272827A1
2999-EP2272841A1
2999-EP2289883A1
2999-EP2292088A1
2999-EP2292576A2
2999-EP2292593A2
2999-EP2292617A1
2999-EP2301936A1
2999-EP2305825A1
2999-EP2311808A1
2999-EP2311829A1
2999-EP2314574A1
3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-nona-2,4,6,8-tetraenoic acid
3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid
3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid
4759-48-2
68070-35-9
A19456
AC1L1KKH
Accutane Roche
AKOS030228441
all trans-Retinoic acid
Amnesteem
ANW-41281
Atra-IV
Bio1_000106
Bio1_000108
Bio1_000110
Bio1_000595
Bio1_000597
Bio1_000599
Bio1_001084
Bio1_001086
Bio1_001088
Bio2_000051
Bio2_000215
Bio2_000220
Bio2_000531
Bio2_000695
Bio2_000700
CBiol_001820
CBiol_001822
CBiol_001824
CHEBI:26536
CHEMBL1235644
CTK8B2898
CTK8F3111
CTK8F7465
DB00755
DivK1c_000903
DivK1c_006792
FT-0601577
FT-0621641
FT-0621993
FT-0674373
FT-0674374
FT-0674376
HMS3266L03
HMS3369K04
HMS3371C15
HMS3654B21
HMS3655M15
KBio1_000903
KBio1_001736
KBio2_000051
KBio2_000215
KBio2_000220
KBio2_002156
KBio2_002619
KBio2_002783
KBio2_002788
KBio2_004724
KBio2_005187
KBio2_005351
KBio2_005356
KBio2_007292
KBio3_000101
KBio3_000102
KBio3_000429
KBio3_000430
KBio3_000439
KBio3_000440
KBio3_002847
KBioGR_000051
KBioGR_000215
KBioGR_000220
KBioGR_001362
KBioSS_000051
KBioSS_000215
KBioSS_000220
KBioSS_002156
KS-00000L4C
KS-00000NS3
KS-0000472F
KSC912Q9R
Lsotretinoin
MCULE-2591910021
MFCD00001551 (95%)
MolPort-006-167-625
NCGC00017280-22
NCGC00094358-17
NCI60_000538
NINDS_000903
Prestwick0_000256
Prestwick0_000257
Prestwick1_000256
Prestwick1_000257
Retisol-A
Sotret
SPBio_002165
SPBio_002291
SPBio_002293
SpecPlus_000696
Spectrum_001676
Spectrum2_001983
Spectrum3_001793
Spectrum4_000901
Stieva-a Forte
SY030154
Tretinoina
Tretinoinum
Vitinoin

US Patents and Regulatory Information for SOLAGE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Almirall SOLAGE mequinol; tretinoin SOLUTION;TOPICAL 020922-001 Dec 10, 1999 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
Baxter
McKesson
Merck
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.